Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianan Hui

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Regenerative Biomaterials|December 22, 2025
Biomimetic bone-vessel interface-on-a-chip for simulating periodontal physiological and pathological microenvironmentChen Chen, Jianan Hui, Tian Tian, et al.
Leukemia Research|August 20, 2025
Time to recovery from neutropenia in patients with newly diagnosed IDH-1 mutated acute myeloid leukemia receiving azacitidine and ivosidenib in the AGILE clinical trialAmir T Fathi, B Douglas Smith, Anne Angiolillo, et al.
Biosensors|May 28, 2022
Analyzing Human Periodontal Soft Tissue Inflammation and Drug Responses In Vitro Using Epithelium-Capillary Interface On-a-ChipLaidi Jin, Ni Kou, Fan An, et al.
ACS Sensors|November 22, 2024
Modular Reconfigurable Approach Toward Noninvasive Wearable Body Net for Monitoring Sweat and Physiological SignalsBo Lin, Fangqi Li, Jianan Hui, et al.
Talanta|December 2, 2023
Detecting EGFR gene amplification using a fluorescence in situ hybridization platform based on digital microfluidicsChuanjie Shen, Cheng Zhan, Zhaoduo Tong, et al.
British Journal of Clinical Pharmacology|September 28, 2020
Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteersTobias Litzenburger, Jürgen Steffgen, Ewald Benediktus, et al.
The New England Journal of Medicine|April 20, 2022
Ivosidenib and Azacitidine in <i>IDH1</i>-Mutated Acute Myeloid LeukemiaPau Montesinos, Christian Recher, Susana Vives, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Regenerative Biomaterials|December 22, 2025
Biomimetic bone-vessel interface-on-a-chip for simulating periodontal physiological and pathological microenvironmentChen Chen, Jianan Hui, Tian Tian, et al.
Leukemia Research|August 20, 2025
Time to recovery from neutropenia in patients with newly diagnosed IDH-1 mutated acute myeloid leukemia receiving azacitidine and ivosidenib in the AGILE clinical trialAmir T Fathi, B Douglas Smith, Anne Angiolillo, et al.
Biosensors|May 28, 2022
Analyzing Human Periodontal Soft Tissue Inflammation and Drug Responses In Vitro Using Epithelium-Capillary Interface On-a-ChipLaidi Jin, Ni Kou, Fan An, et al.
ACS Sensors|November 22, 2024
Modular Reconfigurable Approach Toward Noninvasive Wearable Body Net for Monitoring Sweat and Physiological SignalsBo Lin, Fangqi Li, Jianan Hui, et al.
Talanta|December 2, 2023
Detecting EGFR gene amplification using a fluorescence in situ hybridization platform based on digital microfluidicsChuanjie Shen, Cheng Zhan, Zhaoduo Tong, et al.
British Journal of Clinical Pharmacology|September 28, 2020
Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteersTobias Litzenburger, Jürgen Steffgen, Ewald Benediktus, et al.
The New England Journal of Medicine|April 20, 2022
Ivosidenib and Azacitidine in <i>IDH1</i>-Mutated Acute Myeloid LeukemiaPau Montesinos, Christian Recher, Susana Vives, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Pageof 2